107 filings
Page 5 of 6
UPLOAD
f2fqeuzj35
23 Dec 20
Letter from SEC
12:00am
DRS
2qgaxqb6wb4 q2tt2o
21 Dec 20
Draft registration statement
12:00am
10-Q
skyz f3fey
10 Nov 20
Quarterly report
8:00am
8-K
itub mf6fsrq
10 Nov 20
Prelude Therapeutics Announces Third Quarter 2020 Financial Results
7:37am
8-K
hd81cy6ia3b4
4 Nov 20
Entry into a Material Definitive Agreement
4:09pm
424B4
uxt0lfs33bvvwaltsk
25 Sep 20
Prospectus supplement with pricing info
4:08pm
EFFECT
7car4tt5v
25 Sep 20
Notice of effectiveness
12:15am
S-8
xe009a twqbeed
25 Sep 20
Registration of securities for employees
12:00am
CERT
xrcmq8f
24 Sep 20
Certification of approval for exchange listing
10:01am
CORRESP
9e87 gj0q951dc3
22 Sep 20
Correspondence with SEC
12:00am
CORRESP
ak9i oqn6h8ex4eut5w4
22 Sep 20
Correspondence with SEC
12:00am
8-A12B
8rpd4al8a1k692hqs9t
16 Sep 20
Registration of securities on exchange
12:02pm
S-1/A
zgcjo8 d1v6tm7bx6
16 Sep 20
IPO registration (amended)
11:53am
CORRESP
n4o5bf 0h3
16 Sep 20
Correspondence with SEC
12:00am
CORRESP
koj5h5uhgwm8 jys
9 Sep 20
Correspondence with SEC
12:00am
UPLOAD
21zhecvt9c8vt184a
8 Sep 20
Letter from SEC
12:00am
S-1
znie4ts
4 Sep 20
IPO registration
4:48pm
D
cup t1ggjxdl
28 Aug 20
$50M in equity, sold $50M, 7 investors
2:09pm
DRSLTR
8q7vho 3dh
26 Aug 20
Correspondence regarding draft registration statement
12:00am